{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:38:43Z","timestamp":1792075123117,"version":"4.4.0"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2022,5,18]]},"abstract":"<jats:p>As the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) begins to overlap with the traditional respiratory season in the Northern Hemisphere, simultaneous testing for SARS-CoV-2 and the other common causes of respiratory infections is imperative. This has led to the development of multiplex respiratory assays that include SARS-CoV-2 as a target. One such assay is the BioFire respiratory panel 2.1 (RP2.1), which is an expansion of the original BioFire FilmArray respiratory panel 2 (RP2) to include SARS-CoV-2.<\/jats:p>","DOI":"10.1128\/jcm.00066-22","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:30:25Z","timestamp":1649305825000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":38,"title":["Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples"],"prefix":"10.1128","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-6826","authenticated-orcid":true,"given":"Gregory J.","family":"Berry","sequence":"first","affiliation":[{"name":"Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, New York, USA"},{"name":"Department of Pathology and Laboratory Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhen","sequence":"additional","affiliation":[{"name":"Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Smith","sequence":"additional","affiliation":[{"name":"Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryhana","family":"Manji","sequence":"additional","affiliation":[{"name":"Infectious Disease Diagnostics, Northwell Health Laboratories, Lake Success, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzane","family":"Silbert","sequence":"additional","affiliation":[{"name":"Tampa General Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amorce","family":"Lima","sequence":"additional","affiliation":[{"name":"Tampa General Hospital, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Harington","sequence":"additional","affiliation":[{"name":"Loyola University, Maywood, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"McKinley","sequence":"additional","affiliation":[{"name":"Loyola University, Maywood, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Kensinger","sequence":"additional","affiliation":[{"name":"BioFire Diagnostics, LLC, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crissy","family":"Neff","sequence":"additional","affiliation":[{"name":"BioFire Diagnostics, LLC, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Lu","sequence":"additional","affiliation":[{"name":"BioFire Diagnostics, LLC, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-012420-022445"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14661"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6266"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2606.200299"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.06.011"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31052-7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.041"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e00775"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01945-17"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104538"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102573"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01134-20"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104578"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00743-20"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00783-20"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00821-20"},{"key":"e_1_3_2_19_2","unstructured":"Centers for Disease Control and Prevention. Symptoms and care for RSV. Centers for Disease Control and Prevention Atlanta GA. https:\/\/www.cdc.gov\/rsv\/about\/symptoms.html. Retrieved 14 September 2021."},{"key":"e_1_3_2_20_2","unstructured":"Centers for Disease Control and Prevention. Flu symptoms & diagnosis. Centers for Disease Control and Prevention Atlanta GA. https:\/\/www.cdc.gov\/flu\/symptoms\/index.html. Retrieved 6 January 2022."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20224"},{"key":"e_1_3_2_22_2","unstructured":"Centers for Disease Control and Prevention. 2021. Increased interseasonal respiratory syncytial virus (RSV) activity in parts of the southern United States. Centers for Disease Control and Prevention Atlanta GA. https:\/\/emergency.cdc.gov\/han\/2021\/han00443.asp. Retrieved 14 September 2021."},{"key":"e_1_3_2_23_2","unstructured":"Centers for Disease Control and Prevention. 2020. Testing guidance for clinicians when SARS-CoV-2 and influenza viruses are co-circulating. Centers for Disease Control and Prevention Atlanta GA. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/testing-guidance-for-clinicians.htm. Retrieved 15 September 2021."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.09.004"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.03.007"},{"key":"e_1_3_2_26_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA de novo authorization for BioFire respiratory panel 2.1 (RP2.1). https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/denovo.cfm?id=DEN200031. Retrieved 23 February 2022."},{"key":"e_1_3_2_27_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA emergency use authorization for NeuMoDx SARS-CoV-2 assay. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/136566\/download. Retrieved 23 February 2022."},{"key":"e_1_3_2_28_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA emergency use authorization for BioFire COVID-19 test. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/136356\/download. Retrieved 23 February 2022."},{"key":"e_1_3_2_29_2","unstructured":"U.S. Food and Drug Administration. 2020. FDA emergency use authorization for New York SARS-CoV-2 real-time RT-PCR diagnostic panel. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/135661\/download. Retrieved 23 February 2022."},{"key":"e_1_3_2_30_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA emergency use authorization for Aptima SARS-CoV-2 assay. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/138097\/download. Retrieved 23 February 2022."},{"key":"e_1_3_2_31_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA emergency use authorization for Abbott RealTime SARS-CoV-2. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/136255\/download. Retrieved 23 February 3033."},{"key":"e_1_3_2_32_2","unstructured":"U.S. Food and Drug Administration. 2021. FDA emergency use authorization for Expert Xpress SARS-CoV-2. Food and Drug Administration Washington DC. https:\/\/www.fda.gov\/media\/136316\/download. Retrieved 23 February 2022."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00066-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00066-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T09:03:38Z","timestamp":1652864618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00066-22"}},"subtitle":[],"editor":[{"given":"Yi-Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,18]]}},"alternative-id":["10.1128\/jcm.00066-22"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00066-22","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"2022-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00066-22"}}